Literature DB >> 1936466

Glucose metabolism in obesity and type 2 diabetes.

R C Bonadonna1, R A De Fronzo.   

Abstract

The aim of this review is to provide a comprehensive summary of the subject of glucose metabolism in normal and obese subjects, and in those with type 2 diabetes. The following topics are discussed: Glucose and insulin metabolism, including characterization of the role of various organs in maintaining glucose homeostasis in the basal state and after food. The action of insulin and the concept of insulin resistance, its main characteristics as revealed by studies of glucose metabolism in liver and skeletal muscle, the two organs primarily involved. Changes in insulin secretion in obese subjects and in diabetics are reviewed. Finally, the development of diabetes as a consequence of increasing insulin resistance in the obese diabetic subject is discussed. The principal features--insulin resistance, elevated free fatty acid levels and glucotoxicity--are emphasized. A possible explanation of how obesity leads to diabetes, emphasizing the role played by upper body fat distribution, is provided.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936466

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  10 in total

Review 1.  Regulation of circulating leptin in humans.

Authors:  B Ahrén; H Larsson; C Wilhelmsson; B Näsman; T Olsson
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 2.  Membrane glycoprotein PC-1 and insulin resistance.

Authors:  I D Goldfine; B A Maddux; J F Youngren; L Frittitta; V Trischitta; G L Dohm
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.

Authors:  C G Fanelli; P De Feo; F Porcellati; G Perriello; E Torlone; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  The multifaceted regulation of mitophagy by endogenous metabolites.

Authors:  Ting Zhang; Qian Liu; Weihua Gao; Sheikh Arslan Sehgal; Hao Wu
Journal:  Autophagy       Date:  2021-09-29       Impact factor: 13.391

Review 5.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

Review 6.  Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.

Authors:  Hiroyuki Umegaki
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

7.  Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II.

Authors:  Paola Ungaro; Raffaele Teperino; Paola Mirra; Angela Cassese; Francesca Fiory; Giuseppe Perruolo; Claudia Miele; Markku Laakso; Pietro Formisano; Francesco Beguinot
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

8.  Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure.

Authors:  Jan Polak; Larissa A Shimoda; Luciano F Drager; Clark Undem; Holly McHugh; Vsevolod Y Polotsky; Naresh M Punjabi
Journal:  Sleep       Date:  2013-10-01       Impact factor: 5.849

9.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

Review 10.  Inflammation as a central mechanism in Alzheimer's disease.

Authors:  Jefferson W Kinney; Shane M Bemiller; Andrew S Murtishaw; Amanda M Leisgang; Arnold M Salazar; Bruce T Lamb
Journal:  Alzheimers Dement (N Y)       Date:  2018-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.